|
Volumn 91, Issue 11, 1994, Pages 5104-5108
|
Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat
a,c a a,d c b,c a,b,c |
Author keywords
neuroprotection; substantia nigra
|
Indexed keywords
1 METHYL 4 PHENYLPYRIDINIUM;
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
BRAIN DERIVED NEUROTROPHIC FACTOR;
CILIARY NEUROTROPHIC FACTOR;
MITOCHONDRIAL ENZYME;
NERVE GROWTH FACTOR;
ANIMAL CELL;
ARTICLE;
BRAIN MITOCHONDRION;
CELL PROTECTION;
CELL TRANSPLANTATION;
CONTROLLED STUDY;
DOPAMINERGIC NERVE CELL;
GENETIC ENGINEERING;
NERVE CELL DEGENERATION;
NERVE FIBER TRANSECTION;
NEUROTOXICITY;
NEUROTROPISM;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
RAT;
SUBSTANTIA NIGRA;
1-METHYL-4-PHENYLPYRIDINIUM;
ANIMAL;
BRAIN-DERIVED NEUROTROPHIC FACTOR;
CELL LINE;
CELL SURVIVAL;
CELLS, CULTURED;
FIBROBLASTS;
GENETIC ENGINEERING;
MALE;
NERVE DEGENERATION;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
NEURONS;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, DOPAMINE;
SUBSTANTIA NIGRA;
SUPPORT, U.S. GOV'T, P.H.S.;
ANIMALIA;
|
EID: 0028276809
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.91.11.5104 Document Type: Article |
Times cited : (253)
|
References (51)
|